Dana Hu-Lowe
Corporate Officer/Principal presso ADAGENE INC.
Posizioni attive di Dana Hu-Lowe
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01/11/2021 | - |
Storia della carriera di Dana Hu-Lowe
Precedenti posizioni note di Dana Hu-Lowe
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TURG POIN | Direttore/Membro del Consiglio | 01/04/2019 | 01/10/2021 |
| Corporate Officer/Principal | 01/04/2019 | 01/10/2021 | |
| Wellspring Biosciences, Inc. | Corporate Officer/Principal | 01/03/2013 | 01/03/2019 |
Formazione di Dana Hu-Lowe
| Beijing Normal University | Undergraduate Degree |
| University of Mississippi | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Cina | 3 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ADAGENE INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
| Wellspring Biosciences, Inc. |
- Borsa valori
- Insiders
- Dana Hu-Lowe
- Esperienza
